Übersicht unserer Publikationen

  • Brauner, C., T.O. Lankisch, P. Fytili, J. Jaroszewicz, F. Lehner, H. Barg-Hock, J. Klempnauer, E. Jaeckel, M.P. Manns, H. Wedemeyer, and A.A. Negm. 2014. Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease. Transpl. Infect. Dis. Epub ahead of print. (joint publication with B4, Z2)

  • Gronert Alvarez, A., P. Fytili, P.V. Suneetha, A.R. Kraft, C. Brauner, J. Schlue, T. Krech, F. Lehner, C. Meyer-Heithuis, E. Jaeckel, J. Klempnauer, M.P. Manns, M. Cornberg, and H. Wedemeyer. 2014. Comprehensive phenotyping of regulatory T cells after liver transplantation. Liver Transpl. Epub ahead of print. (joint publication with B4, Z2)

  • Owusu Sekyere, S., P.V. Suneetha, A.R. Kraft, S. Zhang, J. Dietz, C. Sarrazin, M.P. Manns, V. Schlaphoff, M. Cornberg, and H. Wedemeyer. 2014. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. J. Hepatol. Epub ahead of print.

  • Lunemann, S., D.F. Malone, J. Hengst, K. Port, J. Grabowski, K. Deterding, A. Markova, B. Bremer, V. Schlaphoff, M. Cornberg, M.P. Manns, J.K. Sandberg, H.G. Ljunggren, N.K. Bjorkstrom, and H. Wedemeyer. 2014. Compromised function of natural killer cells in acute and chronic viral hepatitis. J. Infect. Dis. 209:1362-1373.

  • Westhaus, S., D. Bankwitz, S. Ernst, K. Rohrmann, I. Wappler, C. Agne, M. Luchtefeld, B. Schieffer, C. Sarrazin, M.P. Manns, T. Pietschmann, S. Ciesek, and T. von Hahn. 2013. Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein. Hepatology 57:1716-1724.

  • von Hahn, T., C. Schiene-Fischer, N.D. Van, S. Pfaender, B. Karavul, E. Steinmann, A. Potthoff, C. Strassburg, N. Hamdi, A.I. Abdelaziz, C. Sarrazin, T. Muller, T. Berg, E. Trepo, H. Wedemeyer, M.P. Manns, T. Pietschmann, and S. Ciesek. 2012. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication. Gastroenterology 143:439-447 e431.

  • Schlaphoff, V., S. Lunemann, P.V. Suneetha, J. Jaroszewicz, J. Grabowski, J. Dietz, F. Helfritz, H. Bektas, C. Sarrazin, M.P. Manns, M. Cornberg, and H. Wedemeyer. 2011. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS pathogens 7:e1002045.

  • Ciesek, S., E. Steinmann, M. Iken, M. Ott, F.A. Helfritz, I. Wappler, M.P. Manns, H. Wedemeyer, and T. Pietschmann. 2010. Glucocorticosteroids increase cell entry by hepatitis C virus. Gastroenterology 138:1875-1884.

  • Ciesek, S., E. Steinmann, H. Wedemeyer, M.P. Manns, J. Neyts, N. Tautz, V. Madan, R. Bartenschlager, T. von Hahn, and T. Pietschmann. 2009. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology 50:1638-1645.

  • von Hahn, T., J.C. Yoon, H. Alter, C.M. Rice, B. Rehermann, P. Balfe, and J.A. McKeating. 2007. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132:667-678.